Knee Osteoarthritis Treatment Market By Treatment Type (Non-Surgical Treatments (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Analgesics, Hyaluronic Acid Injections, Platelet-Rich Plasma (PRP) Therapy, Stem Cell Injections, Physical Therapies, Assistive Devices, Others), Surgical Treatments (Arthroscopy, Osteotomy and Knee Replacement)), By Route of Administration (Oral, Parenteral and Topical), By End User (Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Homecare, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: June 2025
- Report ID: 151629
- Number of Pages: 390
- Format:
-
-
-
- Pfizer Inc Company Profile
- Sanofi S.A.
- Novartis AG Company Profile
- AbbVie Inc. Company Profile
- Amgen Inc.
- Boehringer Ingelheim International GmbH
- Merck & Co., Inc.
- Horizon Therapeutics
- Flexion Therapeutics, Inc.
- Genascence Corporation
- Relation Therapeutics
- Zimmer Biomet
- Stryker Corporation Company Profile
- Smith & Nephew
- Össur
- Mathys Ltd Bettlach
- Anika Therapeutics Inc.
- Bioventus
- Ferring B.V.
- Teva Pharmaceutical Industries Ltd. Company Profile
- Other Key Players
- settingsSettings
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
---|---|---|---|
e-Access | |||
Report Library Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |